Medical Services Advisory Committee - Applications Considered
- 1165.1 – Pre –implantation genetic diagnosis assessment
- 1216.1 – Cystic Fibrosis Transmembrane Regulator
- 1308 – Local anaesthetic (LA) nerve blockade for post-surgical analgesia
- 1360.1 – Specialist dermatology services delivered by asynchronous store and forward technology
- 1392 – Corneal Collagen Cross Linking
- 1397 – mpMRI prostate diagnostic scans
- 1400 – Clinical Neuropsychology Assessment Services
- 1424 – MR-guided biopsy procedures for diagnosis of prostate cancer
- 1429 – Targeted Intraoperative Radiotherapy for Early-Stage Breast Cancer (XOFT® AXXENT®)
- 1432 – Magnetic Resonance Imaging of Patients with Suspected Non- Ischaemic Cardiomyopathy
- 1422 – (SBA) Minimally invasive, lumbar decompression and dynamic stabilisation using an interlaminar device, with no rigid fixation to the vertebral pedicles, of one or two lumbar motion segments
- 1443 – (SBA) Implantable loop recorders for diagnosis of atrial fibrillation in cryptogenic stroke
- 1440 – PD-L1 testing for access to pembrolizumab in treatment naïve patients with locally advanced or metastatic NSCLC (Non-small cell lung cancer) (Co-Dependent Application)